BSE filing, NSE: SHIVA. Summary written from the filing by ALFA Finder's alert engine.
Shivansh Finserve Ltd: key numbers
- Share price
- ₹10.68
- Market cap
- ₹6.66 Cr
- Revenue (annual)
- ₹2.65 Cr
- Net profit (annual)
- ₹0.43 Cr
- P/E (TTM)
- 11.9×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shivansh Finserve Ltd
All →Shivansh Finserve Board Meeting Date
Shivansh Finserve will hold a board meeting on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The filing is a Regulation 29 prior intimation.
Shivansh Finserve Annual General Meeting
Shivansh Finserve issued a corrigendum to its AGM Notice, correcting the shareholding pattern table in the Explanatory Statement regarding the proposed preferential issue. No terms were changed.
Shivansh Finserve Price Movement Clarification
Shivansh Finserve will revise historical shareholding patterns from June 2017 to align with a previously approved 2017 promoter-to-public reclassification, addressing a BSE regulatory query.
Shivansh Finserve Management Change
Mr. Prakhar Agarwal has resigned as the Whole-Time Company Secretary of Shivansh Finserve Limited, effective 16th September 2026.
Shivansh Finserve Annual General Meeting
Shivansh Finserve Limited has announced the book closure dates from 23/09/2026 to 29/09/2026 for its Annual General Meeting to be held on September 29, 2026.
Shivansh Finserve Board Meeting Outcome
Shivansh Finserve approved the acquisition of 19.5% stakes in Startech Infralogistics and Peepal Mining for a combined Rs 81.32 Crore via preferential share swap.
- Value
- ₹81.32 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.